CHMP Adopts Positive Opinion Recommending Hepcludex® (B

-- If Granted by the European Commission, Hepcludex will Become the Only Approved Treatment for HDV in the EU --

... | May 4, 2023

Related Keywords

Foster City , California , United States , Frank Duff , Heiner Wedemeyer , Gilead Sciences , Gilead Sciences Inc , European Medicines Agency , Hannover Medical School , Drug Administration , Committee For Medicinal Products Human Use , Exchange Commission , Nasdaq , European Union , Gilead Sciences In Liver Disease , European Commission , Medicinal Products , Human Use , Marketing Authorisation , Hannover Medical , Senior Vice President , Virology Therapeutic Area Head , Breakthrough Therapy , Orphan Drug , Liver Disease , Private Securities Litigation Reform Act , Marketing Authorization , Quarterly Report , Nc Stock Exchange , News , Information , Press Release , F , Granted , Y , The , European , Epcludex , Hill , Become , Only , Approved , Treatment , Or , Dv , N , U Gild Us3755581036 ,